Dougan G - Search Results

1

Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants.

Douce G, Turcotte C, Cropley I, Roberts M, Pizza M, Domenghini M, Rappuoli R, Dougan G. Douce G, et al. Among authors: dougan g. Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1644-8. doi: 10.1073/pnas.92.5.1644. Proc Natl Acad Sci U S A. 1995. PMID: 7878032 Free PMC article.

2

Characterization of a Salmonella typhimurium aro vaccine strain expressing the P.69 antigen of Bordetella pertussis.

Strugnell R, Dougan G, Chatfield S, Charles I, Fairweather N, Tite J, Li JL, Beesley J, Roberts M. Strugnell R, et al. Among authors: dougan g. Infect Immun. 1992 Oct;60(10):3994-4002. doi: 10.1128/iai.60.10.3994-4002.1992. Infect Immun. 1992. PMID: 1398911 Free PMC article.

3

Recombinant P.69/pertactin: immunogenicity and protection of mice against Bordetella pertussis infection.

Roberts M, Tite JP, Fairweather NF, Dougan G, Charles IG. Roberts M, et al. Among authors: dougan g. Vaccine. 1992;10(1):43-8. doi: 10.1016/0264-410x(92)90418-j. Vaccine. 1992. PMID: 1539459

4

Intranasal immunization using the B subunit of the Escherichia coli heat-labile toxin fused to an epitope of the Bordetella pertussis P.69 antigen.

Lipscombe M, Charles IG, Roberts M, Dougan G, Tite J, Fairweather NF. Lipscombe M, et al. Among authors: dougan g. Mol Microbiol. 1991 Jun;5(6):1385-92. doi: 10.1111/j.1365-2958.1991.tb00785.x. Mol Microbiol. 1991. PMID: 1724057

5

Yersinia enterocolitica aroA mutants as carriers of the B subunit of the Escherichia coli heat-labile enterotoxin to the murine immune system.

O'Gaora P, Roberts M, Bowe F, Hormaeche C, Demarco de Hormaeche R, Cafferkey M, Tite J, Dougan G. O'Gaora P, et al. Among authors: dougan g. Microb Pathog. 1990 Aug;9(2):105-16. doi: 10.1016/0882-4010(90)90084-4. Microb Pathog. 1990. PMID: 2277586

6

Construction and characterization in vivo of Bordetella pertussis aroA mutants.

Roberts M, Maskell D, Novotny P, Dougan G. Roberts M, et al. Among authors: dougan g. Infect Immun. 1990 Mar;58(3):732-9. doi: 10.1128/iai.58.3.732-739.1990. Infect Immun. 1990. PMID: 2407655 Free PMC article.

7

Genetic detoxification of bacterial toxins: a new approach to vaccine development.

Rappuoli R, Douce G, Dougan G, Pizza M. Rappuoli R, et al. Among authors: dougan g. Int Arch Allergy Immunol. 1995 Dec;108(4):327-33. doi: 10.1159/000237176. Int Arch Allergy Immunol. 1995. PMID: 7580303 Review.

8

Characterization of recombinant tetanus toxin derivatives suitable for vaccine development.

Figueiredo D, Turcotte C, Frankel G, Li Y, Dolly O, Wilkin G, Marriott D, Fairweather N, Dougan G. Figueiredo D, et al. Among authors: dougan g. Infect Immun. 1995 Aug;63(8):3218-21. doi: 10.1128/iai.63.8.3218-3221.1995. Infect Immun. 1995. PMID: 7622252 Free PMC article.

9

A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity, PT-9K/129G, is an effective mucosal adjuvant for intranasally delivered proteins.

Roberts M, Bacon A, Rappuoli R, Pizza M, Cropley I, Douce G, Dougan G, Marinaro M, McGhee J, Chatfield S. Roberts M, et al. Among authors: dougan g. Infect Immun. 1995 Jun;63(6):2100-8. doi: 10.1128/iai.63.6.2100-2108.1995. Infect Immun. 1995. PMID: 7768587 Free PMC article.

10

The development of oral vaccines against parasitic diseases utilizing live attenuated Salmonella.

Chatfield SN, Roberts M, Dougan G, Hormaeche C, Khan CM. Chatfield SN, et al. Among authors: dougan g. Parasitology. 1995;110 Suppl:S17-24. doi: 10.1017/s0031182000001451. Parasitology. 1995. PMID: 7784125 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

759 results

Search Page

Filters